Do confidentiality concerns impact pre-exposure prophylaxis willingness in emergency department adolescents and young adults?

Daily oral pre-exposure prophylaxis (PrEP) is recommended to reduce the risk of human immunodeficiency virus (HIV) infection in adolescents and young adults (AYAs) [1]. National electronic pharmacy data suggest that emergency department (ED) providers provide approximately 12 –21% of PrEP prescriptions to AYAs [2]. The ED may be a key access for PrEP given the risk profile of the population served [3,4]. Yet, there have been limited studies to examine what factors impact willingness to take PrEP in ED settings.
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research